Why are you not seeing TZym investors benefiting from this Transaction? I believe this is a very good opportunity for tzym investors A PIPE with 2 promising drug candidates, a great drug discovery platform (MATCH--we're not 100% sure what they will be doing with Match and front loaded with cash.Ocera's pipeline? It's main drug is scheduled to enter phase 2b sometime in 2013, and is an externally sponsored phase 2a study with data to be released in 2014, along with another already developed drug (directly taken from a press release). The fact remains that is highly beneficial for both companies.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.